Oragenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.59

+0.00 (+0.49%)

As of Jun 29, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +771.2% upside

Low Target $3.59

Average Target $5.14

High Target $6.80

Current Price $0.59

Current
$0.59

Target
$5.14

$3.59 $5.14 avg $6.80

Scenario Analysis

Bear Case

$3.59

508.5%

Low target

Base Case

$5.14

+771.2%

Avg target

Bull Case

$6.80

+1,052.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.19

-85.9% from high

52-Week Low

$0.50

+17.1% from low

Target vs 52W High

$5.14

+22.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%